Challenges in clinical trials for high-risk but curable prostate cancer

被引：1
|
作者：
Dorff, Tanya Barauskas [1 ,3 ]
Bryce, Alan H. [2 ]
机构：
[1] City Hope Comprehens Canc Ctr, Dept Med Oncol & Therapeut Res, Duarte, CA USA
[2] City Hope Phoenix, Dept Med Oncol & Therapeut Res, Phoenix, AZ USA
[3] City Hope Comprehens Canc Ctr, Dept Med Oncol & Therapeut Res, 1500 E Duarte Rd, PAV2250, Duarte, CA 91010 USA
来源：
CANCER | 2024年 / 130卷 / 09期
关键词：
androgen-deprivation therapy; clinical trial recruitment and retention; patient advocate; prostate cancer; prostatectomy;
D O I：
10.1002/cncr.35245
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Clinical trials studying neoadjuvant and adjuvant therapy around prostatectomy for patients with high-risk prostate cancer have faced multiple challenges. Patients who have a very good response to neoadjuvant therapy may not wish to continue to adjuvant treatment, and prostate-specific antigen-based end points are difficult to interpret because of variations in testosterone recovery.
引用
收藏
页码：1575 / 1576
页数：2
相关论文
共 50 条
  • [31] Multimodal approaches to high-risk prostate cancer
    Koupparis, A.
    Gleave, M. E.
    CURRENT ONCOLOGY, 2010, 17 : S33 - S37
  • [32] Radical prostatectomy for high-risk prostate cancer
    Ofer Yossepowitch
    James A. Eastham
    World Journal of Urology, 2008, 26 : 219 - 224
  • [33] Radical prostatectomy for locally advanced and high-risk prostate cancer: A systematic review of the literature
    Delporte, G.
    Henon, F.
    Ploussard, G.
    Briganti, A.
    Rizk, J.
    Rozet, F.
    Touijer, K.
    Ouzzane, A.
    PROGRES EN UROLOGIE, 2018, 28 (16): : 875 - 889
  • [34] The curative effect of androgen deprivation therapy alone is insufficient in high-risk prostate cancer
    Choi, Se Young
    Lim, Bumjin
    Chi, Byung Hoon
    Lee, Wonchul
    Kim, Jung Hoon
    Kyung, Yoon Soo
    You, Dalsan
    Kim, Choung-Soo
    MEDICINE, 2021, 100 (31) : E26833
  • [35] Radical prostatectomy for high-risk prostate cancer
    Yossepowitch, Ofer
    Eastham, James A.
    WORLD JOURNAL OF UROLOGY, 2008, 26 (03) : 219 - 224
  • [36] Concurrent chemoradiation for high-risk prostate cancer
    Cooper, Benjamin T.
    Sanfilippo, Nicholas J.
    WORLD JOURNAL OF CLINICAL ONCOLOGY, 2015, 6 (04): : 35 - 42
  • [37] The role for surgeryin high-risk prostate cancer
    Lanchon, Cecilia
    Shariat, Shahrokh F.
    Roupret, Morgan
    WIENER MEDIZINISCHE WOCHENSCHRIFT, 2015, 165 (19-20) : 395 - 400
  • [38] High-risk prostate cancer. Review
    Rozet, F.
    Hennequin, C.
    Fromont, G.
    Mongiat-Artus, P.
    Bastide, C.
    Beuzeboc, P.
    Cormier, L.
    Eiss, D.
    Peyrornaure, M.
    Richaud, P.
    Salomon, L.
    Soulie, M.
    PROGRES EN UROLOGIE, 2011, 21 (13): : 901 - 908
  • [39] Neoadjuvant Therapy in High-Risk Prostate Cancer
    Ashrafi, Akbar N.
    Yip, Wesley
    Aron, Monish
    INDIAN JOURNAL OF UROLOGY, 2020, 36 (04) : 251 - 261
  • [40] The role of surgery for high-risk prostate cancer
    Ucer, Oktay
    Muezzinoglu, Talha
    UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY, 2014, 13 (01): : 21 - 24
12345